Heidi Giordano
Impact in
- Reproductive Medicine top 0.5%
- Ovarian cancer diagnosis and treatment
- Oncology top 0.5%
- PARP inhibition in cancer therapy
Papers in
- Oncology 27
- PARP inhibition in cancer therapy 27
-
- Ovarian cancer diagnosis and treatment 11
- Co-authors
- Robert DeLotto (4 shared papers)Sandra M. Goble (11 shared papers)M. Gregory PETERSON (2 shared papers)Muthusamy Sivaraja (2 shared papers)Lindsey Rolfe (7 shared papers)Susan M. Domchek (3 shared papers)Li Liang (1 shared paper)Steven D. Gore (3 shared papers)
- Journals
- European Journal of Cancer (7 papers)Annals of Oncology (5 papers)Cancer Discovery (2 papers)Genetics (2 papers)Blood (2 papers)
- Partner nations
- United StatesUnited KingdomAustralia
In The Last Decade
Heidi Giordano
36 papers receiving 4.5k citations
Heidi Giordano's Hit Papers
Peers
Comparison fields: 5 of 94
- Reproductive Medicine 1.2k
- Oncology 3.3k
- Cancer Research 433
- Molecular Biology 1.8k
- Genetics 684
Countries citing papers authored by Heidi Giordano
This map shows the geographic impact of Heidi Giordano's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Heidi Giordano with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Heidi Giordano more than expected).
Fields of papers citing papers by Heidi Giordano
This network shows the impact of papers produced by Heidi Giordano. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Heidi Giordano. The network helps show where Heidi Giordano may publish in the future.
Co-authors
The 25 scholars most cited alongside Heidi Giordano, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 37 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Rucaparib maintenance treatment for recurrent ovarian carcinoma after response to platinum therapy (ARIEL3): a randomised, double-blind, placebo-controlled, phase 3 trial Hit paper breakdown → | 2017 | 1394 |
| 2 | Rucaparib in relapsed, platinum-sensitive high-grade ovarian carcinoma (ARIEL2 Part 1): an international, multicentre, open-label, phase 2 trial Hit paper breakdown → | 2016 | 985 |
| 3 | BRCA Reversion Mutations in Circulating Tumor DNA Predict Primary and Acquired Resistance to the PARP Inhibitor Rucaparib in High-Grade Ovarian Carcinoma Hit paper breakdown → | 2018 | 348 |
| 4 | 2017 | 345 | |
| 5 | 2017 | 237 | |
| 6 | 2011 | 223 | |
| 7 | 2017 | 207 | |
| 8 | 2021 | 167 | |
| 9 | 2018 | 154 | |
| 10 | 1998 | 113 | |
| 11 | 2001 | 71 | |
| 12 | 2017 | 68 | |
| 13 | 2019 | 53 | |
| 14 | 1994 | 40 | |
| 15 | 2018 | 35 | |
| 16 | 1995 | 26 | |
| 17 | 2015 | 21 | |
| 18 | 2016 | 21 | |
| 19 | 1998 | 17 | |
| 20 | 2001 | 16 |
About Heidi Giordano
Heidi Giordano is a scholar working on Oncology, Reproductive Medicine, Hematology, Immunology and Molecular Biology, having authored 37 papers that have together received 4.6k indexed citations. Recurring topics across this work include PARP inhibition in cancer therapy (27 papers), Ovarian cancer diagnosis and treatment (11 papers), CRISPR and Genetic Engineering (4 papers), Toxin Mechanisms and Immunotoxins (4 papers), Developmental Biology and Gene Regulation (4 papers), Acute Myeloid Leukemia Research (3 papers), Cell death mechanisms and regulation (3 papers) and BRCA gene mutations in cancer (3 papers). The work is most often cited by research in Reproductive Medicine (1.2k citations), Oncology (3.3k citations), Cancer Research (433 citations), Molecular Biology (1.8k citations) and Genetics (684 citations). Heidi Giordano has collaborated with scholars based in United States, United Kingdom and Australia. Frequent co-authors include Robert DeLotto, Sandra M. Goble, M. Gregory PETERSON, Muthusamy Sivaraja, Lindsey Rolfe, Susan M. Domchek, Li Liang, Steven D. Gore, Lara Maloney and Christopher Ramin Cogle. Their work appears in journals such as European Journal of Cancer, Annals of Oncology, Cancer Discovery, Genetics and Blood.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.